{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:36:43Z","timestamp":1787675803078,"version":"build-2784847793"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.eprac.2020.11.011","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T13:43:43Z","timestamp":1609422223000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Risk Factors of Thyroid Eye Disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Ming Hui","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yip Han","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kameswara Rishi Yeshayahu","family":"Nistala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachariah Gene Wing","family":"Ow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangadhara","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha Peiling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Meng","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2020.11.011_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cen.14296","article-title":"Prevalence of thyroid eye disease in Graves\u2019 disease: a meta-analysis and systematic review","volume":"93","author":"Chin","year":"2020","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy guidelines for the management of Graves\u2019 orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.eprac.2020.11.011_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","article-title":"Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic","volume":"38","author":"Perros","year":"1993","journal-title":"Clin Endocrinol"},{"issue":"suppl 5","key":"10.1016\/j.eprac.2020.11.011_bib4","first-page":"S164","article-title":"Risk of smoking in thyroid-associated orbitopathy","volume":"107","author":"Mann","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.eprac.2020.11.011_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/eje.0.1460153","article-title":"Smoking and thyroid disorders--a meta-analysis","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","article-title":"Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption","volume":"45","author":"Pfeilschifter","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s40618-018-0915-z","article-title":"Relationship between serum cholesterol and Graves\u2019 orbitopathy (GO): a confirmatory study","volume":"41","author":"Lanzolla","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.eprac.2020.11.011_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/thy.2017.0430","article-title":"High serum cholesterol is a novel risk factor for Graves\u2019 orbitopathy: results of a cross-sectional study","volume":"28","author":"Sabini","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2020.11.011_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archopht.1993.01090020051022","article-title":"The initial clinical characteristics of Graves\u2019 orbitopathy vary with age and sex","volume":"111","author":"Kendler","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.eprac.2020.11.011_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/138920211798120844","article-title":"Graves\u2019 ophthalmopathy: a review of immunogenetics","volume":"12","author":"Khalilzadeh","year":"2011","journal-title":"Curr Genomics"},{"key":"10.1016\/j.eprac.2020.11.011_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/thy.2010.1634","article-title":"Risk factors for development or deterioration of Graves\u2019 ophthalmopathy","volume":"20","author":"Stan","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2020.11.011_bib12","first-page":"100207","article-title":"Graves\u2019 disease and mental disorders","volume":"19","author":"Fukao","year":"2019","journal-title":"J\u00a0Clin Transl Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.eprac.2020.11.011_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eprac.2020.11.011_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.eprac.2020.11.011_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.eprac.2020.11.011_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-7-5","article-title":"Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data","volume":"7","author":"Friedrich","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eprac.2020.11.011_bib18","author":"Wells"},{"key":"10.1016\/j.eprac.2020.11.011_bib19","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.eprac.2020.11.011_bib20","first-page":"1","article-title":"Changes in Graves\u2019 ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves\u2019 disease from 2 prospective, randomized, open-label, blinded end point studies","volume":"122","author":"Chen","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.eprac.2020.11.011_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.154998","article-title":"The potential markers involved in newly diagnosed graves\u2019 disease and the development of active Graves\u2019 orbitopathy","volume":"127","author":"He","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.eprac.2020.11.011_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-011-1863-x","article-title":"Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy","volume":"250","author":"Huang","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.eprac.2020.11.011_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000452541","article-title":"Imbalance of Th17\/Treg in different subtypes of autoimmune thyroid diseases","volume":"40","author":"Li","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.eprac.2020.11.011_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10875-008-9213-4","article-title":"Association of Graves\u2019 disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells","volume":"28","author":"Sun","year":"2008","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.eprac.2020.11.011_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1139\/cjpp-2016-0332","article-title":"Poly (ADP-ribose) polymerase-1 (PARP-1) in Chinese patients with Graves\u2019 disease and Graves\u2019 ophthalmopathy","volume":"96","author":"Wu","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.eprac.2020.11.011_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/thy.1998.8.167","article-title":"Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves\u2019 ophthalmopathy and other thyroid and nonthyroid diseases","volume":"8","author":"Wu","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2020.11.011_bib27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1631\/jzus.2006.B0887","article-title":"Association of Graves\u2019 disease and Graves\u2019 ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene","volume":"7","author":"Zhang","year":"2006","journal-title":"J\u00a0Zhejiang Univ Sci B"},{"key":"10.1016\/j.eprac.2020.11.011_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1566524018666180705105753","article-title":"Decreased expression of TIM-3 on Th17 cells associated with ophthalmopathy in patients with Graves\u2019 disease","volume":"18","author":"Zhao","year":"2018","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.eprac.2020.11.011_bib29","first-page":"2296","article-title":"Potential risk factor of Graves\u2019 orbitopathy among Chinese patients: a clinical investigation","volume":"28","author":"Zhou","year":"2017","journal-title":"Biomed Res India"},{"key":"10.1016\/j.eprac.2020.11.011_bib30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-129-8-199810150-00010","article-title":"Cigarette smoking and treatment outcomes in Graves ophthalmopathy","volume":"129","author":"Bartalena","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eprac.2020.11.011_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF03350047","article-title":"More on smoking habits and Graves\u2019 ophthalmopathy","volume":"12","author":"Bartalena","year":"1989","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.eprac.2020.11.011_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF03346790","article-title":"Identification of a subgroup of Graves\u2019 disease patients at higher risk for severe ophthalmopathy after radioiodine","volume":"14","author":"Barth","year":"1991","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.eprac.2020.11.011_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2265.2004.02167.x","article-title":"Serum antibodies to collagen XIII: a further good marker of active Graves\u2019 ophthalmopathy","volume":"62","author":"De Bellis","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40618-016-0587-5","article-title":"Graves\u2019 orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study","volume":"40","author":"Leo","year":"2017","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.eprac.2020.11.011_bib35","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","article-title":"Prevalence and natural history of Graves\u2019 orbitopathy in a large series of patients with newly diagnosed Graves\u2019 hyperthyroidism seen at a single center","volume":"98","author":"Tanda","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2020.11.011_bib36","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1210\/jc.2009-0506","article-title":"Graves\u2019 orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis","volume":"94","author":"Vannucchi","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2020.11.011_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12886-018-0969-x","article-title":"Oxidative stress markers in tears of patients with Graves\u2019 orbitopathy and their correlation with clinical activity score","volume":"18","author":"Choi","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.eprac.2020.11.011_bib38","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1038\/s41598-018-27600-0","article-title":"Comparative assessment of Graves\u2019 disease and main extrathyroidal manifestation, Graves\u2019 ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue","volume":"8","author":"Ji","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.eprac.2020.11.011_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1507\/endocrj.EJ15-0478","article-title":"The relationship between serum adipocytokines and Graves\u2019 ophthalmopathy: a hospital-based study","volume":"63","author":"Kim","year":"2016","journal-title":"Endocr J"},{"key":"10.1016\/j.eprac.2020.11.011_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3341\/kjo.2010.24.5.267","article-title":"Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients","volume":"24","author":"Lee","year":"2010","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.eprac.2020.11.011_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3341\/kjo.2013.27.6.397","article-title":"Prevalence and risk factors for thyroid eye disease among Korean dysthyroid patients","volume":"27","author":"Woo","year":"2013","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.eprac.2020.11.011_bib42","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/09273948.2017.1319960","article-title":"Serum CYR61 is associated with disease activity in Graves\u2019 orbitopathy","volume":"26","author":"Woo","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.eprac.2020.11.011_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/eje.0.1480013","article-title":"Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves\u2019 ophthalmopathy in European and Japanese populations","volume":"148","author":"Bednarczuk","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.17219\/acem\/68991","article-title":"Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with Graves\u2019 orbitopathy","volume":"27","author":"Kapelko-S\u0142owik","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.eprac.2020.11.011_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5603\/EP.2014.0006","article-title":"Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves\u2019 orbitopathy--a prospective study","volume":"65","author":"Kr\u00f3l","year":"2014","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.eprac.2020.11.011_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12020-015-0855-8","article-title":"Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves\u2019 opthalmopathy","volume":"53","author":"Sawicka-Gutaj","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2020.11.011_bib47","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/bjo.84.9.1027","article-title":"Colour Doppler imaging of the orbital vasculature in Graves\u2019 disease with computed tomographic correlation","volume":"84","author":"Alp","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.eprac.2020.11.011_bib48","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/02713683.2016.1198488","article-title":"Choroidal thickness in patients with Graves\u2019 ophthalmopathy","volume":"42","author":"\u00c7al\u0131\u015fkan","year":"2017","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.eprac.2020.11.011_bib49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.gene.2014.06.038","article-title":"Association of PARP-1, NF-\u03baB, NF-\u03baBIA and IL-6, IL-1\u03b2 and TNF-\u03b1 with Graves disease and Graves ophthalmopathy","volume":"547","author":"Niyazoglu","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.eprac.2020.11.011_bib50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1507\/endocrj.43.517","article-title":"Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves\u2019 disease with or without ophthalmopathy","volume":"43","author":"Ozata","year":"1996","journal-title":"Endocr J"},{"key":"10.1016\/j.eprac.2020.11.011_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/IOP.0000000000001437","article-title":"Serum vitamin D deficiency is an independent risk factor for thyroid eye disease","volume":"36","author":"Heisel","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.eprac.2020.11.011_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","article-title":"Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease","volume":"133","author":"Stein","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.eprac.2020.11.011_bib53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/IOP.0000000000000350","article-title":"Predicting the development of orbitopathy in Graves thyroidopathy patients: the potential role of TSI testing","volume":"31","author":"Takakura","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.eprac.2020.11.011_bib54","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-2006-924321","article-title":"Radioiodine therapy of Graves\u2019 hyperthyroidism in patients without pre-existing ophthalmopathy: can glucocorticoids prevent the development of new ophthalmopathy?","volume":"114","author":"Dederichs","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.eprac.2020.11.011_bib55","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2020.11.011_bib56","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/jc.2015-4294","article-title":"Risk factors for Graves\u2019 orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) study","volume":"101","author":"Khong","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2020.11.011_bib57","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/cen.12392","article-title":"Serum selenium status in Graves\u2019 disease with and without orbitopathy: a case-control study","volume":"80","author":"Khong","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib58","first-page":"147","article-title":"Graves\u2019 ophthalmopathy and tobacco smoking","volume":"129","author":"Tallstedt","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib59","first-page":"156","article-title":"Graves\u2019 disease, endocrine ophthalmopathy and smoking","volume":"128","author":"Winsa","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/cen.13122","article-title":"Comparative proteomic analysis of tear fluid in Graves\u2019 disease with and without orbitopathy","volume":"85","author":"Aass","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.1992.tb01445.x","article-title":"Graves\u2019 ophthalmopathy in relation to cigarette smoking and ethnic origin","volume":"36","author":"Tellez","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib62","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2265.2004.02044.x","article-title":"Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves\u2019 ophthalmopathy","volume":"60","author":"Martins","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2006.08.002","article-title":"Decreased nerve growth factor levels in hyperthyroid Graves\u2019 ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases","volume":"35","author":"Moln\u00e1r","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.eprac.2020.11.011_bib64","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4414\/smw.2001.09781","article-title":"Graves\u2019 ophthalmopathy: natural history and treatment outcomes","volume":"131","author":"Noth","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.eprac.2020.11.011_bib65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1993.03500040045034","article-title":"Smoking and risk of Graves\u2019 disease","volume":"269","author":"Prummel","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.eprac.2020.11.011_bib66","first-page":"99","article-title":"Prevalence of Graves\u2019 ophthalmopathy in patients with Graves\u2019 disease presenting to a referral centre in north India","volume":"139","author":"Reddy","year":"2014","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.eprac.2020.11.011_bib67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.15605\/jafes.032.02.09","article-title":"Risk factors associated with the activity and severity of graves\u2019 ophthalmopathy among patients at the university of the Philippines Manila-Philippine General Hospital","volume":"32","author":"Lat","year":"2017","journal-title":"J\u00a0ASEAN Fed Endocr Soc"},{"key":"10.1016\/j.eprac.2020.11.011_bib68","first-page":"39","article-title":"Comparison of thyroid stimulating hormone receptor antibody (Trab) in graves\u2019 disease patients with and without ophtalmopathy","volume":"13","author":"Savitri","year":"2019","journal-title":"New Armen Med J"},{"key":"10.1016\/j.eprac.2020.11.011_bib69","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/thy.2008.0044","article-title":"Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves\u2019 disease","volume":"18","author":"Lim","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2020.11.011_bib70","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/thy.1999.9.1175","article-title":"The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves\u2019 disease identifies a group at markedly increased risk of ophthalmopathy","volume":"9","author":"Khoo","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2020.11.011_bib71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.eye.6701434","article-title":"Pulsatile ocular blood flow in patients with Graves\u2019 ophthalmopathy","volume":"19","author":"Tsai","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.eprac.2020.11.011_bib72","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-18-0039","article-title":"Predictive score for the development or progression of Graves\u2019 orbitopathy in patients with newly diagnosed Graves\u2019 hyperthyroidism","volume":"178","author":"Wiersinga","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib73","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2265.1994.tb02445.x","article-title":"Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy","volume":"40","author":"Metcalfe","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib74","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1089\/thy.2014.0153","article-title":"Smoking induces overexpression of immediate early genes in active Graves\u2019 ophthalmopathy","volume":"24","author":"Planck","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2020.11.011_bib75","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1089\/thy.2013.0654","article-title":"Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves\u2019 disease and ophthalmopathy","volume":"24","author":"Planck","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2020.11.011_bib76","article-title":"The association between cigarette smoking and serum thyroid stimulating hormone, thyroid peroxidase antibodies and thyroglobulin antibodies levels in Chinese residents: a cross-sectional study in 10 cities","volume":"14","author":"Zhang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.eprac.2020.11.011_bib77","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.4158\/EP161350.OR","article-title":"Gender influences the clinical presentation and long-term outcome of Graves disease","volume":"22","author":"Magri","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2020.11.011_bib78","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1089\/thy.2012.0007","article-title":"Genetic profiling in Graves\u2019 disease: further evidence for lack of a distinct genetic contribution to Graves\u2019 ophthalmopathy","volume":"22","author":"Yin","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2020.11.011_bib79","doi-asserted-by":"crossref","first-page":"13096","DOI":"10.1038\/s41598-018-31253-4","article-title":"Graves\u2019 orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model","volume":"8","author":"Schl\u00fcter","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.eprac.2020.11.011_bib80","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/eye.2011.186","article-title":"Hyperthyroid vs hypothyroid eye disease: the same severity and activity","volume":"25","author":"Kashkouli","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.eprac.2020.11.011_bib81","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","article-title":"Association of thyrotrophin receptor antibodies with the clinical features of Graves\u2019 ophthalmopathy","volume":"52","author":"Gerding","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2020.11.011_bib82","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2005-0507","article-title":"A\u00a0prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves\u2019 ophthalmopathy","volume":"90","author":"Perros","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2020.11.011_bib83","article-title":"Antithyroid drugs in Graves\u2019 hyperthyroidism: differences between \u201cblock and replace\u201d and \u201ctitration\u201d regimes in frequency of euthyroidism and Graves\u2019 orbitopathy during treatment","author":"\u017darkovi\u0107","year":"2020","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.eprac.2020.11.011_bib84","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s11745-015-4046-4","article-title":"Hypercholesterolemia induced immune response and inflammation on progression of atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)\/J mice","volume":"50","author":"Rao","year":"2015","journal-title":"Lipids"},{"key":"10.1016\/j.eprac.2020.11.011_bib85","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1037\/0033-2909.106.2.204","article-title":"Smoking, body weight, and their effects on smoking behavior: a comprehensive review of the literature","volume":"106","author":"Klesges","year":"1989","journal-title":"Psychol Bull"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20483909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20483909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:09:06Z","timestamp":1761516546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20483909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1530891X20483909"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2020.11.011","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors of Thyroid Eye Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2020.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}